Andra Ap Fonden Nektar Therapeutics Transaction History

Andra Ap Fonden

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$15.87 - $23.12 $341,205 - $497,080	-21,500 Closed	0 $0
Q3 2019 Nov 19, 2019	SELL	$16.91 - $36.27 $975,707 - $2.09 Million	-57,700 Reduced 72.85%	21,500 $392,000
Q2 2019 Aug 15, 2019	SELL	$31.0 - $36.3 $697,500 - $816,749	-22,500 Reduced 22.12%	79,200 $2.82 Million
Q1 2019 May 14, 2019	BUY	$31.58 - $46.35 $2.68 Million - $3.94 Million	84,900 Added 505.36%	101,700 $3.42 Million
Q3 2018 Oct 16, 2018	BUY	$46.46 - $68.49 $46,460 - $68,490	1,000 Added 6.33%	16,800 $1.02 Million
Q2 2018 Aug 17, 2018	BUY	$46.25 - $104.45 $730,750 - $1.65 Million	15,800 New	15,800 $772,000

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

Stay updated on Andra Ap Fonden with notifications on news.